Investigational drug · Phase 3
varegacestat
Also called: AL102
Not approved by FDA. In 1 industry-sponsored Phase 2 or 3 trial that is active or finished in the last two years, most often for Desmoid, Desmoid Tumor.
Phase 3Last checked: Nov 20, 2026Latest source record: Jun 8, 2026 (newest trial update)Source: ClinicalTrials.govMethods & limitations
Highest phase
Phase 3
Industry-sponsored trials
Phase 2 and 3 trials
1
1 still active
All registered trials
6
Any phase or sponsor naming "varegacestat"
First trial start
2021
Sep 1, 2021
Sponsors
Lead sponsors of its Phase 2 and 3 trials.
All registered trials by phase
Every ClinicalTrials.gov drug study naming "varegacestat", any sponsor or status.
Conditions studied
As listed on its trial records.
- Desmoid
- Desmoid Tumor
Approved drugs for the same conditions: Oncology
Largest trials
Live from ClinicalTrials.gov: studies naming "varegacestat" as an intervention, largest first.
- A Study of AL102 in Patients With Progressing Desmoid TumorsPivotal-lookingActive, not recruiting
Immunome, Inc.Industry
NCT04871282 · 198 participants · Start Sep 1, 2021 · Primary completion Dec 3, 2025
Drug: AL102 · For: Desmoid; Desmoid Tumor
Sites: Pheonix, Arizona; Duarte, California; Santa Monica, California · 53 sites in all
- A Relative Bioavailability and Bioequivalence Study of Varegacestat in Healthy ParticipantsRecruiting
Immunome, Inc.Industry
NCT07610005 · 44 participants (planned) · Start May 21, 2026 · Primary completion May 2027
Drug: Varegacestat Reference Formulation; Varegacestat Test Formulation A and 2 more · For: Healthy
Sites: Tempe, Arizona
Immunome, Inc.Industry
NCT06841315 · 35 participants · Start Mar 7, 2025 · Primary completion Nov 5, 2025
Drug: varegacestat · For: Healthy Volunteer; Hepatic Impairment (HI)
Sites: Orlando, Florida; San Antonio, Texas
Immunome, Inc.Industry
NCT06855264 · 32 participants · Start Feb 24, 2025 · Primary completion Apr 8, 2025
Drug: varegacestat; Placebo and 1 more · For: Healthy Volunteer
Sites: Tempe, Arizona
Immunome, Inc.Industry
NCT06677996 · 22 participants · Start Nov 11, 2024 · Primary completion Dec 30, 2024
Drug: varegacestat; Itraconazole (200 mg) · For: Healthy Volunteer
Sites: Tempe, Arizona
Immunome, Inc.Industry
NCT06845852 · 6 participants · Start Feb 25, 2025 · Primary completion Mar 11, 2025
Drug: varegacestat · For: Healthy Volunteer
Sites: Secaucus, New Jersey
Newest research
PubMed records naming it or its code names, newest first.
- RINGSIDE Phase II Study of Varegacestat for Treatment of Desmoid Tumors: A Randomized Dose-Finding Clinical Trial.
Chugh R, Singh A, Andelkovic V, et al. · J Clin Oncol 2026
- How have gamma-secretase inhibitors changed the treatment landscape for desmoid tumors?
Campos F, Kasper B · Expert Opin Pharmacother 2026
- Repurposing nirogacestat, a gamma secretase enzyme inhibitor in desmoid tumors.
Tansir G, Rastogi S, Gounder MM · Future Oncol 2025
- The Notch signaling pathway in desmoid tumor: Recent advances and the therapeutic prospects.
Zheng C, Huang J, Xu G, et al. · Biochim Biophys Acta Mol Basis Dis 2024
- Chemical characterization and biological effect of exopolysaccharides synthesized by Antarctic yeasts Cystobasidium ongulense AL101 and Leucosporidium yakuticum AL102 on murine innate immune cells.
Rusinova-Videva S, Ognyanov M, Georgiev Y, et al. · World J Microbiol Biotechnol 2022
- Molecular pathogenesis of desmoid tumor and the role of γ-secretase inhibition.
Federman N · NPJ Precis Oncol 2022
Also in development for Desmoid
- FOG-001Phase 21 trial
Parabilis Medicines, Inc. · Cancer, Colorectal Cancer, Solid Tumor
Names are merged from how sponsors list this drug on ClinicalTrials.gov, so an alias can occasionally belong to a related compound. Development status changes faster than registry records do.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.